Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The acquisition aligns with Cardinal's strategic focus on specialty growth and is expected to close by the end of 2025.

The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results and raising its fiscal 2026 EPS outlook.